Results 141 to 150 of about 261,950 (315)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon +11 more
wiley +1 more source
Self-management behaviors to reduce exacerbation impact in COPD patients: a Delphi study
, 2017 Yvonne JG Korpershoek,1,2,* Joyce C Bruins Slot,1,* Tanja W Effing,3,4 Marieke J Schuurmans,1,2 Jaap CA Trappenburg1 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 2Research Group Chronic Illnesses, University of
Trappenburg JCA +4 more
core
Relation of Serum IGF-1 and IGFBP-3 Levels with Acute Exacerbation in Cystic Fibrosis [PDF]
Aim: Cystic fibrosis (CF) is an autosomal recessive genetic disorder primarily affecting the lungs and it is a leading cause of morbidity and mortality. Progressive lung disease and acute pulmonary exacerbations (PEx) are significant contributors to poor
Yasemin Gökdemir +7 more
core +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
Journal of Asthma and Allergy, 2020 Yuki Abe, Masaru Suzuki, Hirokazu Kimura, Kaoruko Shimizu, Hironi Makita, Masaharu Nishimura, Satoshi Konno Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-ku, Sapporo 060-8638 ...
Abe Y +6 more
doaj
Impact of mild exacerbation on COPD symptoms in a Japanese cohort
, 2016 Minako Sato,1 Shotaro Chubachi,1 Mamoru Sasaki,1 Mizuha Haraguchi,1 Naofumi Kameyama,1 Akihiro Tsutsumi,1 Saeko Takahashi,1 Hidetoshi Nakamura,1,2 Koichiro Asano,3 Tomoko Betsuyaku1 1Division of Pulmonary Medicine, Department of Medicine, Keio ...
Chubachi S +9 more
core
, 2023 Petra Kristina Jacobson,1,2 Leili Lind,3,4 Hans Lennart Persson1,2 1Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 2Department of Respiratory Medicine in Linköping, Linköping University, Linköping, Sweden ...
Lind L, Persson HL, Jacobson PK
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries
, 2018 Takeo Ishii,1,2,* Masaharu Nishimura,3,* Asako Akimoto,1 Mark H James,4 Paul Jones4,5,* 1Respiratory Medical Affairs, Development and Medical Affairs, GSK K.K., Tokyo, Japan; 2Graduate School of Medicine, Nippon Medical School, Tokyo, Japan; 3Department ...
James MH +4 more
core
, 2014 Chronic obstructive pulmonary disease (COPD) is a major health problem in the United States. Acute exacerbations of COPD are primarily responsible for the physical, psychological and economic burden of this disease.
Chin, Elizabeth D.
core +1 more source